In immunodeficient mice coinjected with KATO III and PBMCs, neutralization of CCL5 decreased tumor growth, suggesting that GC cells may induce CD4+ T cells to secrete the tumor-promoting CCL5 and may inhibit the anticancer activity of CD8+ cells [106]. The gene discussed is CCL5; the disease is neoplasm.